- Home
- NVCR vs STAA Comparison
NVCR vs STAA Comparison
Compare NVCR & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCR | STAA |
|---|---|---|
| Founded | 2000 | 1982 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | NVCR | STAA |
|---|---|---|
| Price | $14.72 | $22.35 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 10 |
| Target Price | ★ $28.42 | $24.56 |
| AVG Volume (30 Days) | 1.4M | ★ 1.7M |
| Earning Date | 02-26-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $642,269,000.00 | $230,591,000.00 |
| Revenue This Year | $9.75 | N/A |
| Revenue Next Year | $5.62 | $21.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.17 | N/A |
| 52 Week Low | $10.70 | $13.50 |
| 52 Week High | $29.29 | $30.81 |
Technical Indicators
Market Signals| Indicator | NVCR | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 67.15 | 39.94 |
| Support Level | $14.13 | $19.82 |
| Resistance Level | $13.64 | $24.26 |
| Average True Range (ATR) | 0.52 | 1.08 |
| MACD | 0.16 | -0.09 |
| Stochastic Oscillator | 81.96 | 41.87 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.